SANTEN PHARMACEUTICAL CO revenue breakdown overview

SANTEN PHARMACEUTICAL CO revenue for the last year amounted to 279.04 B JPY, the most of which — 260.24 B JPY — came from its highest performing source at the moment, Prescription Drugs, the year earlier bringing 249.58 B JPY. The greatest contribution to the revenue figure was made by Japan — last year it brought SANTEN PHARMACEUTICAL CO 177.37 B JPY, and the year before that — 173.63 B JPY.